CCM
ANIP icon

Cullen Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Cullen Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,113
Closed -$355K – 213
2023
Q3 		$355K Sell
6,113
-6,323
-51% -$365K ﹤0.01% 161
2023
Q2 		$669K Buy
12,436
+2,231
+22% +$98.9K 0.01% 213
2023
Q1 		$405K Buy
+10,205
New +$430K ﹤0.01% 227
2022
Q4 		– Sell
-13,709
Closed -$441K – 202
2022
Q3 		$441K Buy
13,709
+3,086
+29% +$106K ﹤0.01% 222
2022
Q2 		$315K Buy
+10,623
New +$306K ﹤0.01% 247

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return